Literature DB >> 692397

AMP deaminase from human erythrocytes.

G R Nathans, D Chang, T F Deuel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 692397     DOI： 10.1016/s0076-6879(78)51068-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  5 in total

1.  Regulation of the interaction of purified human erythrocyte AMP deaminase and the human erythrocyte membrane.

Authors:  G M Pipoly; G R Nathans; D Chang; T F Deuel
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

2.  Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.

Authors:  P de Miranda; T C Burnette; K K Biron; R L Miller; D R Averett; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Activation of Cl secretion during chemical hypoxia by endogenous release of adenosine in intestinal epithelial monolayers.

Authors:  J B Matthews; K J Tally; J A Smith; A J Zeind; B J Hrnjez
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Mammalian-heart adenylate deaminase: cross-species immunoanalysis of tissue distribution with a cardiac-directed antibody.

Authors:  J K Thakkar; D R Janero; H M Sharif; C Yarwood
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

5.  Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.

Authors:  J E Baggott; W H Vaughn; B B Hudson
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.